The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI-Enabled Imaging Modalities Market Research Report 2025
Synopsis
AI-Enabled Imaging Modalities help to automate and standardize not only workflows but also complex diagnostics to meet the needs of the individual patient. AI-Enabled Imaging Modalities develop with a kind of specific advanced algorithm to improve the accuracy of diagnosis and reduce the time required for diagnosis, helping doctors interpret chest radiographs.
The global AI-Enabled Imaging Modalities market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AI-Enabled Imaging Modalities, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-Enabled Imaging Modalities.
Report Scope
The AI-Enabled Imaging Modalities market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-Enabled Imaging Modalities market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-Enabled Imaging Modalities companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon, Inc.
Agfa
Hologic
Fujifilm
Konica Minolta, Inc.
United Health Imaging
Exo
Nanox
Butterfly Network, Inc.
Hyperfine
Segment by Type
Computed Tomography (CT)
MRI
X-Ray
Ultrasound
Positron Emission Tomography (PET)
Other Modalities
Segment by Application
Cardiology
Oncology
Neurology
Pulmonology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-Enabled Imaging Modalities companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
AI-Enabled Imaging Modalities help to automate and standardize not only workflows but also complex diagnostics to meet the needs of the individual patient. AI-Enabled Imaging Modalities develop with a kind of specific advanced algorithm to improve the accuracy of diagnosis and reduce the time required for diagnosis, helping doctors interpret chest radiographs.
The global AI-Enabled Imaging Modalities market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AI-Enabled Imaging Modalities, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-Enabled Imaging Modalities.
Report Scope
The AI-Enabled Imaging Modalities market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-Enabled Imaging Modalities market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-Enabled Imaging Modalities companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon, Inc.
Agfa
Hologic
Fujifilm
Konica Minolta, Inc.
United Health Imaging
Exo
Nanox
Butterfly Network, Inc.
Hyperfine
Segment by Type
Computed Tomography (CT)
MRI
X-Ray
Ultrasound
Positron Emission Tomography (PET)
Other Modalities
Segment by Application
Cardiology
Oncology
Neurology
Pulmonology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-Enabled Imaging Modalities companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-Enabled Imaging Modalities Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Computed Tomography (CT)
1.2.3 MRI
1.2.4 X-Ray
1.2.5 Ultrasound
1.2.6 Positron Emission Tomography (PET)
1.2.7 Other Modalities
1.3 Market by Application
1.3.1 Global AI-Enabled Imaging Modalities Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Neurology
1.3.5 Pulmonology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-Enabled Imaging Modalities Market Perspective (2019-2030)
2.2 AI-Enabled Imaging Modalities Growth Trends by Region
2.2.1 Global AI-Enabled Imaging Modalities Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-Enabled Imaging Modalities Historic Market Size by Region (2019-2024)
2.2.3 AI-Enabled Imaging Modalities Forecasted Market Size by Region (2025-2030)
2.3 AI-Enabled Imaging Modalities Market Dynamics
2.3.1 AI-Enabled Imaging Modalities Industry Trends
2.3.2 AI-Enabled Imaging Modalities Market Drivers
2.3.3 AI-Enabled Imaging Modalities Market Challenges
2.3.4 AI-Enabled Imaging Modalities Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-Enabled Imaging Modalities Players by Revenue
3.1.1 Global Top AI-Enabled Imaging Modalities Players by Revenue (2019-2024)
3.1.2 Global AI-Enabled Imaging Modalities Revenue Market Share by Players (2019-2024)
3.2 Global AI-Enabled Imaging Modalities Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI-Enabled Imaging Modalities Revenue
3.4 Global AI-Enabled Imaging Modalities Market Concentration Ratio
3.4.1 Global AI-Enabled Imaging Modalities Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-Enabled Imaging Modalities Revenue in 2023
3.5 AI-Enabled Imaging Modalities Key Players Head office and Area Served
3.6 Key Players AI-Enabled Imaging Modalities Product Solution and Service
3.7 Date of Enter into AI-Enabled Imaging Modalities Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-Enabled Imaging Modalities Breakdown Data by Type
4.1 Global AI-Enabled Imaging Modalities Historic Market Size by Type (2019-2024)
4.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Type (2025-2030)
5 AI-Enabled Imaging Modalities Breakdown Data by Application
5.1 Global AI-Enabled Imaging Modalities Historic Market Size by Application (2019-2024)
5.2 Global AI-Enabled Imaging Modalities Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-Enabled Imaging Modalities Market Size (2019-2030)
6.2 North America AI-Enabled Imaging Modalities Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-Enabled Imaging Modalities Market Size by Country (2019-2024)
6.4 North America AI-Enabled Imaging Modalities Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-Enabled Imaging Modalities Market Size (2019-2030)
7.2 Europe AI-Enabled Imaging Modalities Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-Enabled Imaging Modalities Market Size by Country (2019-2024)
7.4 Europe AI-Enabled Imaging Modalities Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-Enabled Imaging Modalities Market Size (2019-2030)
8.2 Asia-Pacific AI-Enabled Imaging Modalities Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-Enabled Imaging Modalities Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-Enabled Imaging Modalities Market Size (2019-2030)
9.2 Latin America AI-Enabled Imaging Modalities Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-Enabled Imaging Modalities Market Size by Country (2019-2024)
9.4 Latin America AI-Enabled Imaging Modalities Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-Enabled Imaging Modalities Market Size (2019-2030)
10.2 Middle East & Africa AI-Enabled Imaging Modalities Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Koninklijke Philips N.V.
11.1.1 Koninklijke Philips N.V. Company Detail
11.1.2 Koninklijke Philips N.V. Business Overview
11.1.3 Koninklijke Philips N.V. AI-Enabled Imaging Modalities Introduction
11.1.4 Koninklijke Philips N.V. Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.1.5 Koninklijke Philips N.V. Recent Development
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Company Detail
11.2.2 Siemens Healthineers AG. Business Overview
11.2.3 Siemens Healthineers AG. AI-Enabled Imaging Modalities Introduction
11.2.4 Siemens Healthineers AG. Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.2.5 Siemens Healthineers AG. Recent Development
11.3 General Electric Company
11.3.1 General Electric Company Company Detail
11.3.2 General Electric Company Business Overview
11.3.3 General Electric Company AI-Enabled Imaging Modalities Introduction
11.3.4 General Electric Company Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.3.5 General Electric Company Recent Development
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Detail
11.4.2 Canon, Inc. Business Overview
11.4.3 Canon, Inc. AI-Enabled Imaging Modalities Introduction
11.4.4 Canon, Inc. Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.4.5 Canon, Inc. Recent Development
11.5 Agfa
11.5.1 Agfa Company Detail
11.5.2 Agfa Business Overview
11.5.3 Agfa AI-Enabled Imaging Modalities Introduction
11.5.4 Agfa Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.5.5 Agfa Recent Development
11.6 Hologic
11.6.1 Hologic Company Detail
11.6.2 Hologic Business Overview
11.6.3 Hologic AI-Enabled Imaging Modalities Introduction
11.6.4 Hologic Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.6.5 Hologic Recent Development
11.7 Fujifilm
11.7.1 Fujifilm Company Detail
11.7.2 Fujifilm Business Overview
11.7.3 Fujifilm AI-Enabled Imaging Modalities Introduction
11.7.4 Fujifilm Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.7.5 Fujifilm Recent Development
11.8 Konica Minolta, Inc.
11.8.1 Konica Minolta, Inc. Company Detail
11.8.2 Konica Minolta, Inc. Business Overview
11.8.3 Konica Minolta, Inc. AI-Enabled Imaging Modalities Introduction
11.8.4 Konica Minolta, Inc. Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.8.5 Konica Minolta, Inc. Recent Development
11.9 United Health Imaging
11.9.1 United Health Imaging Company Detail
11.9.2 United Health Imaging Business Overview
11.9.3 United Health Imaging AI-Enabled Imaging Modalities Introduction
11.9.4 United Health Imaging Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.9.5 United Health Imaging Recent Development
11.10 Exo
11.10.1 Exo Company Detail
11.10.2 Exo Business Overview
11.10.3 Exo AI-Enabled Imaging Modalities Introduction
11.10.4 Exo Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.10.5 Exo Recent Development
11.11 Nanox
11.11.1 Nanox Company Detail
11.11.2 Nanox Business Overview
11.11.3 Nanox AI-Enabled Imaging Modalities Introduction
11.11.4 Nanox Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.11.5 Nanox Recent Development
11.12 Butterfly Network, Inc.
11.12.1 Butterfly Network, Inc. Company Detail
11.12.2 Butterfly Network, Inc. Business Overview
11.12.3 Butterfly Network, Inc. AI-Enabled Imaging Modalities Introduction
11.12.4 Butterfly Network, Inc. Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.12.5 Butterfly Network, Inc. Recent Development
11.13 Hyperfine
11.13.1 Hyperfine Company Detail
11.13.2 Hyperfine Business Overview
11.13.3 Hyperfine AI-Enabled Imaging Modalities Introduction
11.13.4 Hyperfine Revenue in AI-Enabled Imaging Modalities Business (2019-2024)
11.13.5 Hyperfine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
